Australian Palliative Care Conference 2017

pall con 2

Dr Andrew Potter presenting at APCC 2017

Genesis CancerCare Active at APCC 2107

This year the biennial Australian Palliative Care Conference was held at the Adelaide Convention Centre and attracted both national and international key note speakers. This pre-eminent event was for anyone with an interest in quality palliative care at the end of life.

The theme for the conference was “Connection with Community”. The conference attracted over 800 clinicians, researchers, allied health professionals, educators and carers who all have a passion for palliative care. A lot of those who attended are the decision makers of today, the future leaders of tomorrow, policy influencers and those involved in the latest research.

Adelaide Radiotherapy Centre and Genesis Cancer Care saw this as an ideal opportunity to inform and educate those attending about optimizing the use of radiation therapy in the palliative setting. By having a trade display Genesis Cancer Care, Marketing Managers, Beverley Blakeway (Genesis Cancer Care QLD) and Rose Powell (Adelaide Radiotherapy Centre) were able to engage conference attendees and inform them about not only what radiation therapy can do in the palliative setting, but better inform them about the Genesis Cancer Care network and what our vision is. They were ably assisted by Dana O’Brien, who has just started working at ARC.

A highlight of the conference was hearing Adelaide Radiotherapy’s own Radiation Oncologist, Dr Andrew Potter, present to a captive audience of clinicians on Advances in palliative radiotherapy. His abstract submission, which was accepted as an oral presentation, is listed below for those requiring further information.

Advances in palliative radiotherapy: Tailoring technology to individualise patient care

Andrew Potter, Radiation Oncologist, Adelaide Radiotherapy Centre – Genesis Cancer Care

Advances in cancer diagnosis and treatment have resulted in improved survival for many cancer types. Patients now routinely have access to multiple lines of treatment including surgery, radiotherapy, chemotherapy and an increasing range of targeted drug therapies. With this increase in treatment options, patients are increasingly surviving for longer with metastatic disease, effectively lengthening the duration of the palliative phase of treatment.

Radiotherapy has long been recognised as an effective treatment for relief of symptoms including pain, bleeding, masses and brain metastases, and is conventionally delivered as a short course of treatment when symptoms occur. Recent developments in radiotherapy technology now allow clinicians to more carefully tailor treatment to individual patients’ circumstances. From locally advanced but incurable disease, to oligometastases or extensive metastatic disease, new radiotherapy techniques including stereotactic body radiotherapy (SABR/SBRT), stereotactic radiosurgery (SRS) and intensity modulated radiotherapy (IMRT/VMAT) allow radiation to be delivered selectively to tumours whilst minimising dose to surrounding normal tissues, thereby reducing treatment-related toxicities.

This presentation showcases the development of new technology and techniques available for use in palliative radiation therapy, and illustrates their practical application to patients at varying stages of their palliative care journey, aiming to optimise outcomes and minimise toxicities. With a broader awareness of the role of radiotherapy in palliation, patients, their families, and their care team are encouraged to seek out the benefits of radiation therapy for each individual’s situation.

pall con 1

Genesis Cancer Care Marketing Managers, Bev Blakeway (QLD) & Rose Powell (SA) at the conference

South Australian Breast Cancer Study Group spend an evening at ARC

sabcsg 1

Recently the South Australian Breast Cancer Study Group (SABCSG) spent an evening with ARC at our Tennyson Centre location.

Everyone was welcomed by the chairperson of SABCSG, Dr Bev Fosh and an introduction of the evening’s proceedings was given by Dr Phuong Tran, Radiation Oncologist, with ARC.

Guest Speakers for the evening were Dr Caroline Connell who spoke on Radiotherapy updates in breast cancer, which included recent research information, Dr Joshua Sappiatzer who presented on normal tissue sparing techniques in breast radiotherapy, such as DIBH (deep inspiration breath hold) and Dr Andrew Potter who gave us an insight into Stereotactic irradiation in metastatic breast cancer. All presenters are Radiation Oncologists, with ARC.

Following on from dinner and the well-received presentations, attendees went on a tour of Adelaide radiotherapy’s facilities, where they followed the patient’s journey from simulation to treatment. This is a fantastic way for all attending to gain a valuable understanding of not only the process of radiation treatment but also the immense detail that goes into planning individual, targeted, conformed, healthy tissue sparing treatment.

Adelaide Radiotherapy Centre would like to thank SABCSG for the opportunity to present and showcase our site.

sabcsg 2

sabcsg 3

Sister Jenni’s farewell

jenni 2

Today we celebrated with Chinese and bubbles for Jenni as we say goodbye and thank you for her 18 years of service at Adelaide Radiotherapy Centre. There was a period there where we weren’t sure if the guest of honour would make it but in true Jenni style she was able to sweet talk her doctor and make sure she was back from her appointment on time.

We wish Jenni all the best in her retirement and hope she has the best time on her four week European adventure.

Thank you again Jenni for your service and you will be missed by the team here.

Prostate Cancer Foundation of Australia Webcast


Prostate Cancer Foundation of Australia (PCFA) invites you to attend our Ask The Experts Webcast. Join us for an engaging panel discussion with leading health professionals and be informed on what you need to know about prostate cancer.

WHEN Wednesday 20 Sept 2017 7:00pm – 8:00pm (AEST)

WHERE Online – join via computer, smart phone and tablet.

Registration is essential.

Hosted by SBS Presenter Ricardo Goncalves, this interactive forum will cover key topics such as:

  • Risk factors and diagnosis
  • Navigating different options after a diagnosis
  • Treatment and management of side effects
  • Support available to men and their families
  • Questions from the audience

To register and for further information go to

Not available to join us live?
Still register and stay connected to view webcast post recording via

Daffodil Day at ARC 2017

daffodil 1

Daffodils were in abundance everywhere you looked at our treatment sites on Friday morning, adding a splash of colour to help brighten our patient’s day!

This year every patient attending any of our four locations received a daffodil from our staff to show our support in the united effort to fight cancer, including the lovely Sharron, who was at our St Andrew’s site this morning.

The daffodil is the international symbol of hope for everyone affected by cancer. Daffodil Day is one of the largest fundraising events in the Southern Hemisphere and 2017 marks the 31st year that Australians have been supporting this event.

At ARC we have been fundraising for the Cancer Council, selling Daffodil pens, badges, clips and Dougal bears and even purchased our 500 daffodils from the Cancer Council. This year the Cancer Council is aiming to raise in excess of $400,000 in South Australia. All money raised will continue to provide support to the 9,700 people diagnosed with cancer in SA each year and also to aid in vital cancer research.

Read more ...

Follow us on Facebook

  • Our People

    Adelaide Radiotherapy Centre operates a best practice multidisciplinary team that consists of radiation oncologists, radiation therapists... Read More
  • Radiotherapy

    What is Radiotherapy? More than one in three people will develop cancer in their lifetime and over half of these patients will require radiotherapy at Read More
  • 1
  • 2

Genesis Logo Small.pngGenesisCare is Australia’s leading provider of radiation oncology, cardiology and sleep treatments. We exist to fill the treatment gap for the biggest disease burdens in Australia - cancer and heart care - in an environment of substantial unmet demand from an ageing population. Click here to learn more